HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

monoclonal antibody SGN-30

in phase II clinical trials for treatment of Hodgkin's disease
Also Known As:
SGN-30 monoclonal antibody
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kim, Youn H: 1 article (10/2009)
2. Korman, Neil J: 1 article (10/2009)
3. Lorenz, Jennie: 1 article (10/2009)
4. Zic, John: 1 article (10/2009)
5. Sievers, Eric L: 1 article (10/2009)
6. Reddy, Sunil A: 1 article (10/2009)
7. Pinter-Brown, Lauren: 1 article (10/2009)
8. Kennedy, Dana A: 1 article (10/2009)
9. Duvic, Madeleine: 1 article (10/2009)
10. Law, Che-Leung: 1 article (12/2007)

Related Diseases

1. Primary Cutaneous Anaplastic Large Cell Lymphoma
2. Lymphomatoid Papulosis
3. Mycosis Fungoides
4. Neoplasms (Cancer)
5. Hodgkin Disease (Hodgkin's Disease)